Glycemic, hormone, and appetite responses to monosaccharide ingestion in patients with type 2 diabetes

Metabolism: Clinical and Experimental

Volumn 51, Issue 8, 2002, Pages 949-957

  Vozzo, Rosalie ^a,b   Baker, Ben ^a,b   Wittert, Gary A ^a,b   Wishart, Judith M ^a,b   Morris, Howard ^a,b   Horowitz, Michael ^a,b   Chapman, Ian ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; MONOSACCHARIDE;

ADULT; AGED; APPETITE; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC DIET; DIABETIC OBESITY; DIET RESTRICTION; DISEASE DURATION; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HORMONE RESPONSE; HUMAN; INSULIN BLOOD LEVEL; MALE; MEAL; MICROPARTICLE ENZYME IMMUNOASSAY; MONITOR; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SATIETY; SINGLE BLIND PROCEDURE; SUGAR INTAKE;

EID: 0036347912     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.34012     Document Type: Article

References (45)

1. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses
2. Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects
3. The metabolic response to various doses of fructose in type II diabetic subjects
4. Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans
5. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
6. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine
7. Effects of fructose and glucose preloads on subsequent food intake
8. Comparative effects of fructose, aspartame, glucose, and water preloads on calorie and macronutrient intake
9. Effects of pure vs. mixed starch fructose loads on food intake
10. Effects of glucose and fructose solutions on food intake and gastric emptying in nonobese women
11. Glucagon-like peptide-1: A potent regulator of food intake in humans
12. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
13. Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
14. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger
15. Gastrointestinal correlates of the development of hunger in man
16. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus
17. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1
18. Radioimmunoassay of gastric inhibitory polypeptide in plasma
19. Effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age
20. Appetite regulation by carbohydrate: Role of blood glucose and gastrointestinal hormones
21. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate
22. Stimulation of insulin secretion by fructose ingested with protein in people with untreated type 2 diabetes
23. An insulinogenic effect of oral fructose in humans during postprandial hyperglycemia
24. The glycemic index of food
25. Quantitation of the pathways followed in the conversion of fructose to glucose in liver
26. Fructose in the diabetic diet
27. The postprandial state and the risk of atherosclerosis
28. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
29. Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: A 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism
30. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes
31. Lipid metabolism in non-insulin-dependent diabetes: Effects of long-term treatment with fructose-supplemented mixed meals
32. Metabolic effects of fructose supplementation in diabetic individuals
33. Long-term effects of dietary fructose on carbohydrate metabolism in non-insulin-dependent diabetes mellitus
34. Metabolic consequence of two-week fructose feeding in diabetic subjects
35. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
36. The metabolic role of GIP: Physiology and pathology
37. Gastrointestinal peptides and insulin secretion
38. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro
39. Effect of fructose and other sugars on islet function in vitro
40. Insulin secretion mechanisms and glucose metabolism in isolated islets
41. The insulin response to intravenous fructose in relation to blood glucose levels
42. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas
43. Metabolic effects of fructose and glucose: Implications for food intake
44. Assessment of fat-free mass using bioelectrical impedance measurements of the human body
45. Hemoglobin A1c by HPLC with the Pharmacia Mono S HR 5/N cation-exchange column: Influence of sample protein load on optimal chromatographic conditions